Education first.
Our goal is to help readers understand peptide science, research methods, evidence quality, safety limitations, and U.S. regulatory context without overstating what research can prove.
Evidence over hype
We do not treat early-stage findings, animal studies, or marketing claims as proven human outcomes.
Clear uncertainty
Where evidence is limited, conflicting, preliminary, or absent, we aim to say so directly.
Reader independence
Our content is intended to inform readers, not pressure them into medical or purchasing decisions.
How we weigh scientific evidence.
Different kinds of research answer different questions. We consider study design, population, sample size, controls, endpoints, duration, adverse-event reporting, replication, and relevance to the claim being discussed.
Evidence hierarchy we use as a guide
This is not a rigid scoring system; quality can vary within every category.
What sources we prefer.
We prioritize sources readers can inspect directly and that are appropriate for the specific claim being made.
Primary and authoritative sources
When available, we prefer:
Sources we treat cautiously
We may reference these for context, but not as the sole support for important medical or scientific claims:
How an article moves from draft to publication.
| Stage | What happens | Our standard |
|---|---|---|
| 1. Topic selection | We define the educational question and scope. | The topic should have a clear reader benefit and not be framed around unsupported promotional claims. |
| 2. Research | Relevant primary and authoritative sources are gathered. | Important factual claims should be traceable to credible sources. |
| 3. Drafting | The article is written in plain language. | Known facts, uncertainty, limitations, and regulatory status should be distinguished clearly. |
| 4. Editorial review | Structure, wording, sourcing, and claims are checked. | Unsupported medical claims, exaggerated conclusions, and misleading wording are removed. |
| 5. Scientific review | Where appropriate, a qualified reviewer may assess technical accuracy. | We only identify a reviewer and their credentials if that person actually reviewed the content. |
| 6. Publication | The article is published with source links and review information. | Author, review date, and meaningful conflicts should be disclosed where applicable. |
| 7. Updates | Material is reviewed when evidence or regulatory information changes. | Substantive changes should update the review date and, when appropriate, include a correction note. |
Medical and health claims
We do not present a compound as proven to diagnose, treat, cure, prevent, enhance, or produce a specific medical result unless the statement is supported by appropriate evidence and accurately reflects regulatory status.
Dosing and self-administration
Our educational content does not provide individualized dosing, injection instructions, self-treatment protocols, or guidance intended to help a reader use an experimental or prescription product without appropriate clinical care.
Commercial interests should not control scientific conclusions.
Readers should be able to understand when commercial relationships, sponsorships, affiliate arrangements, or other interests could influence how content is perceived.
Advertising separation
Advertising or sponsorship should be visually distinguishable from editorial content and should not determine our scientific conclusions.
Conflict disclosure
Meaningful financial, professional, or commercial conflicts should be disclosed when relevant to the topic.
No disguised promotion
Educational articles should not be presented as independent science while functioning as hidden product advertisements.
AI-assisted content
AI tools may be used to assist with drafting, organization, summarization, formatting, or research workflows, but AI output is not treated as an authoritative source.
Images and illustrations
Scientific illustrations, generated images, and diagrams may be used for education or design, but they should not misrepresent research results, imply clinical proof, or appear to be real patient outcomes when they are not.
We correct meaningful errors.
Scientific and regulatory information can change. When we identify a material error, outdated regulatory statement, broken interpretation, or misleading wording, we aim to correct it promptly.
Minor corrections
Spelling, formatting, broken links, and other changes that do not alter meaning may be fixed without a formal correction note.
Material corrections
Changes that alter the meaning of a scientific, medical, regulatory, or safety claim should be documented clearly.
Evidence updates
Articles may be revised when important new research, FDA action, safety information, or clinical guidance becomes available.
Reader feedback and correction requests
We welcome factual corrections, source suggestions, and concerns about wording or conflicts of interest. Please include the article title, the statement in question, and supporting source material where possible.
Our standard is transparency.
Readers should be able to see where information came from, how strong the evidence is, who reviewed the content, and when important uncertainty remains.